Manolakopoulos, Spilios

Publishing since 1997 (Senior)

Has published 36 publications in 14 years

Number of publications published per year by Manolakopoulos, Spilios. (Source : PubMed)

Distribution of publications types for Manolakopoulos, Spilios. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Georgiou A, Kafiri G, Tiniakos DG, Margariti K, Manolakopoulos S, Manesis EK, Archimandritis AJ. Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease.  J. Clin. Gastroenterol.  2010;44;4  
•  Dimitroulopoulos D, Petroulaki E, Manolakopoulos S, Anagnostou O, Tsaklakidou D, Xinopoulos D, Tsamakidis K, Tzourmakliotis D, Paraskevas E. Peginterferon/ribavirin treatment achieves a higher compliance rate than interferon/ribavirin combination in patients chronically infected with HCV on methadone maintenance.  Eur J Gastroenterol Hepatol  2009;21;12  
•  Tsochatzis E, Manolakopoulos S, Papatheodoridis GV, Hadziyannis E, Triantos C, Zisimopoulos K, Goulis I, Tzourmakliotis D, Akriviadis E, Manesis EK, Archimandritis AJ. Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study.  Aliment. Pharmacol. Ther.  2009;30;9  
•  Manolakopoulos S, Triantos C, Theodoropoulos J, Vlachogiannakos J, Kougioumtzan A, Papatheodoridis G, Tzourmakliotis D, Karamanolis D, Burroughs AK, Archimandritis A, Raptis S, Avgerinos A. Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension.  J. Hepatol.  2009;51;3  
•  Papatheodoridis GV, Manolakopoulos S. EASL clinical practice guidelines on the management of chronic hepatitis B: the need for liver biopsy.  J. Hepatol.  2009;51;1  
•  Vlachogiannakos J, Saveriadis AS, Viazis N, Theodoropoulos I, Foudoulis K, Manolakopoulos S, Raptis S, Karamanolis DG. Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis.  Aliment. Pharmacol. Ther.  2009;29;9  
•  Tsochatzis E, Papatheodoridis GV, Manolakopoulos S, Tiniakos DG, Manesis EK, Archimandritis AJ. Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B.  Scand. J. Gastroenterol.  2009;44;6  
•  Tsochatzis EA, Manolakopoulos S, Papatheodoridis GV, Archimandritis AJ. Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications.  Scand. J. Gastroenterol.  2009;44;1  
•  Papatheodoridis GV, Manolakopoulos S, Archimandritis AJ. Current treatment indications and strategies in chronic hepatitis B virus infection.  World J. Gastroenterol.  2008;14;45  
•  Papatheodoridis GV, Manesis EK, Manolakopoulos S, Elefsiniotis IS, Goulis J, Giannousis J, Bilalis A, Kafiri G, Tzourmakliotis D, Archimandritis AJ. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?  Hepatology  2008;48;5  

[ See timeline ] [ See all publications ]